Welcome to RB Bioworks
Tirzepatide is a synthetic dual incretin receptor agonist designed to target both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It has been studied in preclinical and large-scale clinical trials for its role in metabolic regulation, glucose homeostasis, and energy balance signaling pathways.
Tirzepatide represents a next-generation incretin-based peptide engineered to enhance insulinotropic activity while modulating appetite and metabolic biomarkers.
Structure: 39 amino acid synthetic peptide (lipidated for extended half-life)
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
